GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 817 filers reported holding GLAXOSMITHKLINE PLC in Q3 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $238,000 | -93.7% | 6,674 | -93.5% | 0.02% | -93.5% |
| Q4 2020 | $3,786,000 | -8.4% | 102,869 | -6.3% | 0.38% | -17.2% |
| Q3 2020 | $4,132,000 | +11.1% | 109,766 | +20.4% | 0.46% | +6.4% |
| Q2 2020 | $3,718,000 | +25.1% | 91,161 | +16.3% | 0.44% | +6.3% |
| Q1 2020 | $2,971,000 | +8.6% | 78,406 | +34.7% | 0.41% | +31.7% |
| Q4 2019 | $2,735,000 | +28.0% | 58,196 | +16.2% | 0.31% | +13.0% |
| Q3 2019 | $2,137,000 | +13.6% | 50,062 | +6.5% | 0.28% | +8.7% |
| Q2 2019 | $1,881,000 | -0.8% | 46,991 | +3.5% | 0.25% | -3.8% |
| Q1 2019 | $1,897,000 | +12.3% | 45,392 | +2.7% | 0.26% | +1.9% |
| Q4 2018 | $1,689,000 | +69.7% | 44,210 | +78.5% | 0.26% | +90.4% |
| Q3 2018 | $995,000 | +3.6% | 24,764 | +3.9% | 0.14% | 0.0% |
| Q2 2018 | $960,000 | – | 23,823 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |